Brensocatib
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications
The Drug Update: Recent drug approvals, summer 2026 edition.
Journal: The Nurse practitioner
Published: July 31, 2026
Efficacy and Safety of Brensocatib in Participants of Asian Race with Non-cystic Fibrosis Bronchiectasis: A Subgroup Analysis of the ASPEN Trial.
Journal: Pulmonary therapy
Published: May 29, 2026
Pharmacotherapy options and drug development in bronchiectasis: spotlight on dipeptidyl-peptidase inhibitors.
Journal: Expert opinion on pharmacotherapy
Published: April 28, 2026
Brensocatib in non-cystic fibrosis bronchiectasis: targeting neutrophil-driven inflammation through DPP-1 inhibition.
Journal: Annals of medicine and surgery (2012)
Published: April 07, 2026
The effectiveness and value of brensocatib for the treatment of non-cystic fibrosis bronchiectasis.
Journal: Journal of managed care & specialty pharmacy
Published: February 27, 2026
LTF promotes central nervous system leukemia progression via neutrophil serine proteases.
Journal: Frontiers in pharmacology
Published: February 18, 2026
Cystic fibrosis year in review 2025.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: February 16, 2026
Targeting Neutrophil Function as Therapy for Hidradenitis Suppurativa.
Journal: International journal of molecular sciences
Published: February 04, 2026
Anti-inflammatory therapies for bronchiectasis.
Journal: Current opinion in infectious diseases
Published: January 27, 2026
Bronchiectasis in the precision medicine era: pathogenesis and therapeutic advances.
Journal: Journal of thoracic disease
Published: January 21, 2026
The Role of Dipeptidyl Peptidase Inhibitors in Pulmonary Diseases.
Journal: Biomedicines
Published: January 20, 2026
Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review.
Journal: British journal of pharmacology
Published: January 16, 2026
Last Updated: 09/26/2026